 |
 |
|
|
RESÚMENES ABRIL 2005 |
Psychotic Disorders & Antipsychotics
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Jeffrey
A. Lieberman, Gary D. Tollefson, Cecil Charles, Robert Zipursky, Tonmoy Sharma,
Rene S. Kahn, Richard S. E. Keefe, Alan I. Green, Raquel E. Gur, Joseph McEvoy,
Diana Perkins, Robert M. Hamer, Hongbin Gu, Mauricio Tohen, for the HGDH Study
Group
Arch Gen Psychiatry. 2005;62:361-370
Increased Caudate Dopamine D2 Receptor Availability
as a Genetic Marker for Schizophrenia
Jussi
Hirvonen, Theo G. M. van Erp, Jukka Huttunen, Sargo Aalto, Kjell Nĺgren, Matti
Huttunen, Jouko Lönnqvist, Jaakko Kaprio, Jarmo Hietala, Tyrone D. Cannon
Arch Gen Psychiatry. 2005;62:371-378
Regionally
Specific Disturbance of Dorsolateral Prefrontal–Hippocampal Functional Connectivity
in Schizophrenia
Andreas
S. Meyer-Lindenberg, Rosanna K. Olsen; Philip D. Kohn; Timothy Brown; Michael
F. Egan, Daniel R. Weinberger, Karen Faith Berman
Arch Gen Psychiatry. 2005;62:379-386
Efficacy and safety of direct transition to risperidone long-acting
injectable in patients treated with various antipsychotic therapies.
Moller, Hans-Jurgen; Llorca, Pierre-Michel;
Sacchetti, Emilio; Martin, Stephen D; Medori, Rossella; Parellada, Eduard;
StoRMi Study Group
International Clinical Psychopharmacology.
20(3):121-130, May 2005
Reduction in hospital stay of chronic schizophrenic patients after
long-term clozapine treatment
Ahn, Yong Min; Chang, Jae Seung; Kim, Yeni;
Lee, Kyu Young; Kim, Jong Hoon; Kim, Seong Chan; Maeng, So Jin; Kim, Yong Sik
International Clinical Psychopharmacology.
20(3):157-161, May 2005
An inter-ethnic comparison study of clozapine dosage, clinical response
and plasma levels
Ng, Chee H; Chong, Siow-Ann; Lambert, Tim;
Fan, Agnes; Peter Hackett, L; Mahendran, Rathi; Subramaniam, Mythily; Schweitzer,
Isaac
International Clinical Psychopharmacology.
20(3):163-168, May 2005
Naturalistic observation on the hepatic enzyme changes in patients
treated with either risperidone or olanzapine alone
Pae, Chi-Un; Lim, Hyun-Kook; Kim, Tae-Suk;
Kim, Jung-Jin; Lee, Chang-Uk; Lee, Soo-Jung; Lee, Chul; Paik, In-Ho
International Clinical Psychopharmacology. 20(3):173-176,
May 2005
Weight
gain and new onset diabetes associated with olanzapine and risperidone
Farwell WR, Stump TE, Wang J, Tafesse E, L'Italien G, Tierney WM
J Gen Intern Med. 2004 Dec;19(12):1200-5
Margaret A. Fonder,
Kristi A. Sacco, Angelo Termine, Brigid S. Boland, Aisha A. Seyal, Melissa M.
Dudas, Jennifer C. Vessicchio and Tony P. George
Biological Psychiatry. Volume 57, Issue 7, 15 March 2005, Pages
802-808
The effects of
antipsychotic medication on factor and cluster structure of neurologic
examination abnormalities in schizophrenia
Gerald Goldstein,
Richard D. Sanders, Steven D. Forman, Thaddeus Tarpey, John A. Gurklis, Daniel
P. Van Kammen and Matcheri S. Keshavan
Schizophrenia
Research. Volume 75, Issue 1, 1 June 2005, Pages 55-64
Relationship of
neuromotor disturbances to psychosis symptoms in first-episode
neuroleptic-naďve schizophrenia patients
Leonardo Cortese,
Michael P. Caligiuri, Ashok K. Malla, Rahul Manchanda, Jatinder Takhar and Raj
Haricharan
Schizophrenia
Research. Volume 75, Issue 1, 1 June 2005, Pages 65-75
Enrique
Baca-Garcia, M. Mercedes Perez-Rodriguez, Carmen Diaz Sastre, Jeronimo
Saiz-Ruiz and Jose de Leon
Schizophrenia
Research. Volume 75, Issue 1, 1 June 2005, Pages 77-81
Antidepressive effects of traditional and second generation
antipsychotics: a review of the clinical data
Hans-Jürgen Möller
European Archives of Psychiatry and Clinical
Neuroscience 2005;Volume 255, Number 2: 83 - 93
How representative of everyday clinical populations are schizophrenia
patients enrolled in clinical trials?
M. Riedel,
M. Strassnig, N. Müller, P. Zwack and H.-J. Möller
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 2: 143 - 148
Clinical effects of COX–2 inhibitors on cognition in schizophrenia
N. Müller,
M. Riedel, M. J. Schwarz and R. R. Engel
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 2: 149 - 151
Richard N. Bergman,
and Marilyn Ader
J Clin Psychiatry 2005;66:504-514
Pregnancy Outcome of Women Using Atypical Antipsychotic Drugs: A Prospective Comparative Study
Kate McKenna,
Gideon Koren, Maria Tetelbaum, Lynda Wilton, Saad Shakir, Orna Diav-Citrin,
Andrea Levinson, Robert B. Zipursky, and Adrienne Einarson
J Clin Psychiatry 2005;66:444-449
Predictors and markers of clozapine response
Carmen Chung
and Gary Remington
Psychopharmacology 2005; Volume 179, Number
2: 317 - 335
Tardive
Dystonia
Skidmore F, Reich SG
Curr Treat Options Neurol. 2005 May;7(3):231-236
Sex differences in
concomitant medication with benzodiazepines or antidepressants in first-break
schizophrenic patients treated with antipsychotic medication
Claudia A.W.
Rijcken, H. Knegtering, Richard Bruggeman, Hilde Tobi and Lolkje T.W. de
Jong-van den Berg
Psychiatry Research. Volume 134, Issue 2, 15 April 2005, Pages
143-150
Effect of
neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and
IL-1 receptor antagonist in schizophrenic patients
Pinkhas Sirota,
Meital Meiman, Ruth Herschko and Hanna Bessler
Psychiatry Research. Volume 134, Issue 2, 15 April 2005, Pages
151-159
An
open study of risperidone liquid in the acute phase of schizophrenia.
Yoshimura R, Nakamura J,
Shinkai K, Goto M, Yamada Y, Kaji K, Kakihara S, Ueda N, Kohara K, Ninomiya H,
Egami H, Maeda H.
Hum Psychopharmacol. 2005 Apr 13; [Epub ahead of
print]
Prevalence of
sexual dysfunction in patients with schizophrenia: international variation and
underestimation
Martin Dossenbach,
Andrew Hodge, Martin Anders, Béla Molnár,
Dalia Peciukaitiene, Irena Krupka-Matuszczyk, Mihai Tatu,
Victor Bondar, Jan Pecenak, Tatjana Gorjanc and
Margaret McBride
The International Journal of Neuropsychopharmacology
(2005), 8:2:195-201
Clozapine,
risperidone, olanzapine, and conventional antipsychotic drug effects on
glucose, lipids, and leptin in schizophrenic patients
Robert
C. Smith, Jean-Pierre Lindenmayer, Nigel Bark,
Jessy Warner-Cohen, Sumathi Vaidhyanathaswamy and
Amaresh Khandat
The International Journal of Neuropsychopharmacology
(2005), 8:2:183-194
Effects of
quetiapine and haloperidol on body mass index and glycaemic control: a
long-term, randomized, controlled trial
Robin Emsley,
H. Jadri Turner, Juan Schronen, Karien Botha, Retha Smit
and Piet P. Oosthuizen
The International Journal of Neuropsychopharmacology
(2005), 8:2:175-182
HANNELE HEILÄ,
JARI HAUKKA, JAANA SUVISAARI and JOUKO LÖNNQVIST
Psychological Medicine (2005), 35:5:725-732
Effects of
olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia
spectrum disorders
Milena
Korostenskaja, Kastysis Dapsys, Aldona Siurkute, Valentinas Maciulis, Osvaldas
Ruksenas and Seppo Kähkönen